Kinetic Study on the Mechanism of Tissue Distribution of Vinblastine

journal of pharmacobio-dynamics

Volumn 11, Issue 10, 1988, Pages 651-661

  Wierzba, Konstanty ^a   Sugiyama, Yuichi ^a   Iga, Tatsuji ^a   Hanano, Manabu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

microtubule; pharmacokinetics; tissue distribution; tissue tubulin; vinblastine; Vinca drug

Indexed keywords

COLCHICINE; RADIOISOTOPE; TUBULIN; VINBLASTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; CYTOSOL; DRUG BINDING; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PHARMACOKINETICS;

ANIMAL; BINDING SITES; CELL NUCLEUS; COLCHICINE; CYTOSOL; KIDNEY; KINETICS; LIVER; MALE; MICE; PROTEIN BINDING; TISSUE DISTRIBUTION; TUBULIN; VINBLASTINE;

EID: 0023811839     PISSN: 0386846X     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb1978.11.651     Document Type: Article

References (25)

1. H. H. Weiss, M. D. Walker and P. H. Wiernik: Neurotoxicity of commonly used antineoplastic agents, N. Engl. J. Med., 291, 75-81 (1974).
2. R. J. Owellen, C. A. Hartke, R. M. Dickerson and F. O. Hains: Inhibition of tubulin microtubule polymerization by drugs of the Vinca alkaloids class, Cancer Res., 36, 1499-1502 (1976).
3. R. O. Sandberg and H. Glaukman: Effect of vinblastine on rat liver with special consideration to composition, intracellular migration, secretion, and degradation of lipoprotein particles and albumin, Exp. Mol. Pathol., 36,242-261 (1982).
4. M. A. Jordan, R. H. Himes and L. Wilson: Comparison of the effects of vinblastine, vincristine, vindesine and vinepidine on microtubule dynamics and cell proliferation in vitro, Cancer Res., 45, 2741-2747 (1985).
5. B. Bhattacharyya and J. Wolff: Tubulin aggregation and disaggregation: mediation by two distinct vinblastinebinding sites, Proc. Natl. Acad. Sci. U.S.A., 73, 2375-2378 (1976).
6. M. C. Castle, D. A. Margileth and V. T. Oliveria: Distribution and excretion of 3H-vincristine in the rat and the dog, Cancer Res., 36,3684-3689 (1976).
7. R. L. Noble, P. W. Gout, L. L. Wijcik, H. F. Hebden and C. T. Beer: The distribution of 3H-vinblastine in tumor and host tissues of Nb rats bearing a transplantable lymphoma which is highly sensitive to the alkaloid, Cancer Res., 37,1455-1460 (1977).
8. R. J. Owellen, M. Blair, A. van Tosh and F. C. Hains: Determination of tissue concentrations of Vinca alkaloids by radoimmunoassay, Cancer Treat. Rep., 65, 469-475 (1981).
9. H. W. Culp, H. W. Daniels and R. E. McMahon: Disposition and tissue levels of 3H-vindesine in rats, Cancer Res., 37,3053-3056 (1977).
10. D. J. Stewart, K. Lu, R. S. Benjamin, M. E. Leavens, M. Luna, H. Y. Yap and T. I. Loo: Concentrations of vinblastine in human intracerebral tumor and other tissues, J. Neuro-Oncol., 1, 139-144 (1983).
11. J. A. Houghton, L. G. Williams, R. K. Dodge, S. L. George, B. J. Hazelton and P. J. Houghton: Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids, Biochem. Pharmacol., 36, 81-88 (1987).
12. P. Sherline, C. K. Bodwin and D. M. Kipnis: A new colchicine binding assay for tubulin, Anal. Biochem., 62, 400-407 (1974).
13. K. Wierzba, Y. Sugiyama, K. Okudaira, T. Iga and M. Hanano: Tubulin as a major determinant of vincristine distribution, J. Pharm. Sci., 76, 872-875 (1987).
14. E. Baraona, F. Finkelman, Y. Matsuda and C. C. Lieber: A modified colchicine-binding assay for the measurement of total and microtubule-derived tubulin in rat liver, Anal. Biochem., 130, 302-310 (1983).
15. K. Yamaoka, Y. Tanigawara, T. Nakagawa and T. Uno: A pharmacokinetic analysis program (MULTI) for microcomputer, J. Pharmacobio-Dyn., 4, 879 — 885
16. T. Terasaki, T. Iga, Y. Sugiyama and M. Hanano: Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: Interorgan, and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs, J. Pharm. Sci., 73, 1359-1363 (1984).
17. M. M. Cornwell, M. M. Gottesman and I. H. Paston: Increased vinblastine binding to membrane vesicles from multi-drug resistant KB cells, J. Biol. Chem., 261,7921-7928 (1986).
18. R. J. Owellen, A. R. Owens and D. W. Donigian: The binding of vincristine, vinblastine, and colchicine to tubulin, Biochem. Biophys. Res. Commun., 47, 685-691 (1972).
19. J. C. Lee, D. Harrison and S. N. Timasheff: Interaction of vinblastine with calf brain microtubule protein, J. Biol. Chem., 250,9276-9282 (1975).
20. D. W. Donigian and R. J. Owellen: Interaction of vinblastine, vincristine and colchicine with serum proteins, Biochem. Pharmacol., 22, 2113-2119 (1973).
21. W. H. Steele, D. J. King, H. E. Barber, G. M. Hawksworth, A. A. Dawson and J. C. Petrie: The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkins disease, Eur. J. Clin. Pharmacol, 24,683-687 (1983).
22. W. H. Steele, D. J. Haughton and H. E. Barber: Binding of vinblastine to recrystallized human aracidic glycoprotein, Cancer Chemother. Pharmacol., 10, 40—42
23. K. Wierzba, Y. Sugiyama, K. Okudaira, T. Iga and M. Hanano: Uptake of vinblastine by isolated rat hepatocytes: Relationship to the intracellular binding, J. Pharm. Sci., submitted.
24. K. Wierzba, Y. Sugiyama, K. Okudaira, T. Iga and M. Hanano: Uptake of colchicine, a microtubular system disrupting agent by rat hepatocytes, Pharm. Res., submitted.
25. V. A. Levin: Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability, J. Med. Chem., 23, 682-684 (1980).